Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Pharmas In Trend To Focus On Targeted Drugs

This article was originally published in PharmAsia News

Executive Summary

Indian pharmaceutical companies are joining what appears to be a global trend of pharmas to shift their emphases to specialized or targeted drugs rather than relying on blockbusters. Dr. Reddy's Laboratories, Wockhardt and Lupin Pharmaceuticals are, as are several multinational drug makers, increasingly focused on cancer molecules, monoclonal antibodies and vaccines. Part of the change has come about because of moves by generics makers into supplying medicines used in primary care. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts